The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions
Abstract
Proton magnetic resonance spectroscopy ((1)H MRS) of the breast has been proposed as an adjunct to the magnetic resonance imaging (MRI) examination to improve the specificity of distinguishing malignant breast tumors from benign breast tumors. In this review, we carry out a pooled analysis of the clinical breast (1)H MRS studies undertaken to date to determine the factors that influence the diagnostic performance of this method. In total, five studies of breast (1)H MRS from four independent centers around the world have been published to date. Altogether, 153 tumors were examined, 100 of which were confirmed histologically to be malignant and 53 of which were benign. The lesions presenting a detectable composite choline signal in their corresponding (1)H MR spectra were diagnosed as malignant, whereas the lesions with no choline signal were diagnosed as benign. The sensitivity and specificity of breast (1)H MRS for detecting breast cancer were 83% (95% confidence interval [CI] = 73% to 89%) and 85% (95% CI = 71% to 93%), respectively, and both values could be as high as 92% after technical exclusions. In a subgroup of 20 young women, the sensitivity and the specificity of the method approached 100%. The factors limiting the sensitivity of the examination were mainly technical. The use of the composite choline signal as a marker for malignancy in breast (1)H MRS is a robust method with highly reliable interpretation, because it is based on the appearance of a single peak. The method is likely to provide even better results with technologic advances in breast MRS that lead to the improved detection of the composite choline signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer
Orel, S. G., & Schnall, M. D. (2001) · Radiology · doi:10.1148/radiology.220.1.r01jl3113 · Cited by 759
Effect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography
Kerlikowske, K. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540010035027 · Cited by 624
Aboagye, E. O., & Bhujwalla, Z. M. (1999) · PubMed · Cited by 546
Preul, M. C., Caramanos, Z., Collins, D. L., Villemure, J.-G., Leblanc, R., Olivier, A., Pokrupa, R., & Arnold, D. L. (1996) · Nature Medicine · doi:10.1038/nm0396-323 · Cited by 523
Warner, E., Plewes, D. B., Shumak, R. S., Catzavelos, G. C., Di Prospero, L. S., Yaffe, M. J., Goel, V., Ramsay, E., Chart, P. L., Cole, D. E. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3524 · Cited by 461
Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates
Chu, K. C., Tarone, R. E., Kessler, L. G., Ries, L. A. G., Hankey, B. F., Miller, B. A., & Edwards, B. K. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1571 · Cited by 430
Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Goffin, J., Chappuis, P. O., Wong, N., & Foulkes, W. D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1754 · Cited by 284
Mapping pathophysiological features of breast tumors by MRI at high spatial resolution
Degani, H., Gusis, V., Weinstein, D., Fields, S., & Strano, S. (1997) · Nature Medicine · doi:10.1038/nm0797-780 · Cited by 268
Katz‐Brull, R., Seger, D., Rivenzon‐Segal, D., Rushkin, E., & Degani, H. (2002) · PubMed · Cited by 221
Self-citation
Cited by
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Choline metabolism in malignant transformation
Glunde, K., Bhujwalla, Z. M., & Ronen, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3162 · Cited by 823
Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts
Kreis, R. (2004) · NMR in Biomedicine · doi:10.1002/nbm.891 · Cited by 430
Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer
Glunde, K., Jie, C., & Bhujwalla, Z. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3829 · Cited by 380
Metadata
- Authors
- Katz-Brull, R.
- Venue
- CancerSpectrum Knowledge Environment
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-21
- Volume
- 94
- Issue
- 16
- Pages
- 1197-1203
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2116309666
- Cited by
- 267
- References
- 18
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions. https://app.cochat.ai/papers/10.1093/jnci/94.16.1197
- The paper
- Katz-Brull, R. (2002). Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions. CancerSpectrum Knowledge Environment. https://doi.org/10.1093/jnci/94.16.1197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.